OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
600230$15.7755

Cangzhou Dahua Co Ltd

Commodity ChemicalsVerified

Cangzhou Dahua maintains a conservative capital structure with a debt-to-equity ratio of 0.16, indicating limited leverage relative to its equity base. The company's liquidity position is assessed as medium, with a current ratio of 0.67, suggesting potential short-term liquidity constraints. Despite a market price of 15.77, the company trades at a high price-to-earnings ratio of 211.59, reflecting either market optimism or earnings compression. Profitability metrics for Cangzhou Dahua are weak compared to industry norms. The company's return on equity (ROE) is 0.77%, and return on assets (ROA) is 0.52%, both significantly below the typical performance of firms in the Commodity Chemicals industry. Gross profit of 333.64 million CNY represents 7.3% of revenue, indicating thin margins in a highly competitive sector. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes in China. No material revenue is attributed to international markets, and the company does not report segment-specific performance data. Growth prospects for Cangzhou Dahua appear muted. The company's operating cash flow of 139.59 million CNY and free cash flow of 296.26 million CNY suggest limited capacity for reinvestment or shareholder returns. Capital expenditures of -203.30 million CNY indicate a reduction in investment, which may signal a defensive posture or operational constraints. No significant revenue growth is projected for the current or next fiscal year. The company faces moderate risk from liquidity constraints and a high price-to-earnings ratio, which may not be sustainable in a low-margin industry. The risk assessment indicates low dilution potential, with no recent or disclosed share issuance activity. However, the negative net cash position after subtracting total debt raises concerns about short-term financial flexibility. No recent filings or transcripts have been disclosed that would indicate material changes in the company's operations or strategy. The absence of public commentary on strategic initiatives or market expansion efforts suggests a stable but unambitious business trajectory.

30-day price · 600230-4.92 (-23.7%)
Low$15.71High$20.95Close$15.80As of25 May, 00:00 UTC
Profile
CompanyCangzhou Dahua Co Ltd
Ticker600230.SS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Cangzhou Dahua Co Ltd is a Chinese chemicals company that produces and sells commodity chemicals, primarily serving industrial and manufacturing sectors.

Classification. Cangzhou Dahua is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Cangzhou Dahua maintains a conservative capital structure with a debt-to-equity ratio of 0.16, indicating limited leverage relative to its equity base. The company's liquidity position is assessed as medium, with a current ratio of 0.67, suggesting potential short-term liquidity constraints. Despite a market price of 15.77, the company trades at a high price-to-earnings ratio of 211.59, reflecting either market optimism or earnings compression. Profitability metrics for Cangzhou Dahua are weak compared to industry norms. The company's return on equity (ROE) is 0.77%, and return on assets (ROA) is 0.52%, both significantly below the typical performance of firms in the Commodity Chemicals industry. Gross profit of 333.64 million CNY represents 7.3% of revenue, indicating thin margins in a highly competitive sector. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes in China. No material revenue is attributed to international markets, and the company does not report segment-specific performance data. Growth prospects for Cangzhou Dahua appear muted. The company's operating cash flow of 139.59 million CNY and free cash flow of 296.26 million CNY suggest limited capacity for reinvestment or shareholder returns. Capital expenditures of -203.30 million CNY indicate a reduction in investment, which may signal a defensive posture or operational constraints. No significant revenue growth is projected for the current or next fiscal year. The company faces moderate risk from liquidity constraints and a high price-to-earnings ratio, which may not be sustainable in a low-margin industry. The risk assessment indicates low dilution potential, with no recent or disclosed share issuance activity. However, the negative net cash position after subtracting total debt raises concerns about short-term financial flexibility. No recent filings or transcripts have been disclosed that would indicate material changes in the company's operations or strategy. The absence of public commentary on strategic initiatives or market expansion efforts suggests a stable but unambitious business trajectory.
Key takeaways
  • Cangzhou Dahua operates in a low-margin commodity chemicals industry with weak profitability metrics.
  • The company's high price-to-earnings ratio suggests market optimism that is not supported by current earnings performance.
  • Liquidity constraints and a negative net cash position after debt raise concerns about short-term financial flexibility.
  • The company lacks geographic and segment diversification, increasing exposure to regional economic and regulatory risks.
  • Growth prospects are limited, with no significant capital expenditures or revenue expansion expected in the near term.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$4.56B
Gross profit$333.6M
Operating income$37.0M
Net income$30.9M
R&D
SG&A
D&A
SBC
Operating cash flow$139.6M
CapEx-$203.3M
Free cash flow$296.3M
Total assets$5.90B
Total liabilities$1.89B
Total equity$4.01B
Cash & equivalents
Long-term debt$638.9M
Valuation
Market price$15.77
Market cap$6.53B
Enterprise value$7.17B
P/E211.6
Reported non-GAAP P/E
EV/Revenue1.6
EV/Op income193.7
EV/OCF51.3
P/B1.6
P/Tangible book1.6
Tangible book$4.01B
Net cash-$638.9M
Current ratio0.7
Debt/Equity0.2
ROA0.5%
ROE0.8%
Cash conversion4.5%
CapEx/Revenue-4.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
Metric600230Activity
Op margin0.8%5.5% medp25 -0.0% · p75 10.8%below median
Net margin0.7%4.1% medp25 0.1% · p75 8.8%below median
Gross margin7.3%20.5% medp25 12.4% · p75 29.7%bottom quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-4.5%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity16.0%37.1% medp25 10.3% · p75 82.0%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-25 02:53 UTC#636b0741
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 00:09 UTCJob: c96b1a2d